Levothyroxine-sodium Bioequivalence Trial With Oral Single Dose Administration

Status:
COMPLETED

Trial end date:
2022-05-22

Target enrollment:

Participant gender:

PHASE1

Berlin-Chemie AG Menarini Group

Tablets
Thyroxine